Erratum to: Practical Considerations for the Use of Daratumumab, a Novel CD38 Monoclonal Antibody, in Myeloma

Affiliations

¹ Hematology Department, University Hospital Hôtel-Dieu, Place Ricordeau, 44093, Nantes, France. philippe.moreau@chu-nantes.fr.
² VU University Medical Center, Amsterdam, The Netherlands.
³ University Hospital Navarra, Pamplona, Spain.
⁴ Karolinska University Hospital Huddinge, Stockholm, Sweden.
⁵ Hadassah Medical Center, Jerusalem, Israel.
⁶ University School of Medicine, Bologna, Italy.
⁷ St James's University Hospital, Leeds, UK.
⁸ Catholic University of Leuven, Leuven, Belgium.
⁹ Julius Maximilian University, Würzburg, Germany.
¹⁰ Wilhelminen hospital, Vienna, Austria.
¹¹ Kantonsspital St. Gallen, St. Gallen, Switzerland.
¹² University of Torino, Torino, Italy.
¹³ University Hospital Lille, Lille, France.
¹⁴ Vejle Hospital and University of Southern Denmark, Vejle, Denmark.
¹⁵ University Athens School of Medicine, Athens, Greece.
¹⁶ University of Giessen, Giessen, Germany.
¹⁷ Erasmus MC Cancer Insitute, Rotterdam, The Netherlands.
¹⁸ University Hospital of Salamanca, Salamanca, Spain.

Published Erratum

Philippe Moreau et al. Drugs. 2016 Jun.

. 2016 Jun;76(9):989-990.

doi: 10.1007/s40265-016-0590-3.

¹ Hematology Department, University Hospital Hôtel-Dieu, Place Ricordeau, 44093, Nantes, France. philippe.moreau@chu-nantes.fr.
² VU University Medical Center, Amsterdam, The Netherlands.
³ University Hospital Navarra, Pamplona, Spain.
⁴ Karolinska University Hospital Huddinge, Stockholm, Sweden.
⁵ Hadassah Medical Center, Jerusalem, Israel.
⁶ University School of Medicine, Bologna, Italy.
⁷ St James's University Hospital, Leeds, UK.
⁸ Catholic University of Leuven, Leuven, Belgium.
⁹ Julius Maximilian University, Würzburg, Germany.
¹⁰ Wilhelminen hospital, Vienna, Austria.
¹¹ Kantonsspital St. Gallen, St. Gallen, Switzerland.
¹² University of Torino, Torino, Italy.
¹³ University Hospital Lille, Lille, France.
¹⁴ Vejle Hospital and University of Southern Denmark, Vejle, Denmark.
¹⁵ University Athens School of Medicine, Athens, Greece.
¹⁶ University of Giessen, Giessen, Germany.
¹⁷ Erasmus MC Cancer Insitute, Rotterdam, The Netherlands.
¹⁸ University Hospital of Salamanca, Salamanca, Spain.

No abstract available

Erratum for

Practical Considerations for the Use of Daratumumab, a Novel CD38 Monoclonal Antibody, in Myeloma.
Moreau P, van de Donk NW, San Miguel J, Lokhorst H, Nahi H, Ben-Yehuda D, Cavo M, Cook G, Delforge M, Einsele H, Zweegman S, Ludwig H, Driessen C, Palumbo A, Facon T, Plesner T, Dimopoulos M, Sondergeld P, Sonneveld P, Mateos MV. Moreau P, et al. Drugs. 2016 May;76(8):853-67. doi: 10.1007/s40265-016-0573-4. Drugs. 2016. PMID: 27113582 Review.